Stay updated on Favezelimab Combo in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Favezelimab Combo in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Favezelimab Combo in Advanced Solid Tumors Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page history now shows a new revision label v3.6.6, replacing the previous v3.6.5, indicating a minor update to the page's revision metadata.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page shows Revision: v3.6.5 instead of Revision: v3.6.4, indicating a deployed update to the site's build/version information. This change does not alter content or navigation.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page's site revision updated to v3.6.4, replacing v3.6.3. This reflects a new interface version for the page.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page’s revision tag was updated from v3.6.2 to v3.6.3, indicating a new release/version of the page. This is reflected in the revision history as the most recent change.SummaryDifference0.0%

- Check78 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2. This indicates a newer version of the page has been published.SummaryDifference0.0%

- Check92 days agoChange DetectedRecruitment is closed for the study. The latest revision tag is v3.6.0, replacing v3.5.5.SummaryDifference0.2%

Stay in the know with updates to Favezelimab Combo in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Favezelimab Combo in Advanced Solid Tumors Clinical Trial page.